The U.S. Food & Drug Administration said yesterday that warnings about heart or stomach risks must be placed on all pain relievers in a class called “non-steroidal anti-inflammatory drugs.” It excluded aspirin and acetaminophen, which is sold under the brand name Tylenol.

[Read more →]

The Food and Drug Administration has asked Pfizer to voluntarily remove Bextra (valdecoxib) from the market. FDA is also asking manufacturers of all marketed prescription Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), including Celebrex (celecoxib), to revise their products to include a boxed warning, highlighting the potential for increased risk of cardiovascular (CV) events and the well-described, [...]

[Read more →]